Log In
Print
BCIQ
Print
Print this Print this
 

Vectibix, panitumumab

Also known as: formerly ABX-EGF

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionHuman mAb against EGFR1
Molecular Target Epidermal growth factor receptor 1 (EGFR1) (HER1) (ErbB1)
Mechanism of ActionBinds epidermal growth factor (EGF) receptor; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$20.9M

$20.9M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today